Skip to main content
OpenTrials
Completed

NCT Number: NCT01495325

Effect of Woodsmoke on Vascular Function

Exposure to air pollution is a well established risk factor for the development of heart disease. Firefighters are exposed to excess air pollution in the form of wood smoke during the extinguishing of forest or woodland fires. Heart attacks in on-duty firefighters have been linked to specific duties and in particular fire suppression, but the reasons for this increase in risk are not well understood. Exposure to wood smoke may alter blood vessel function and increase blood clot formation to explain the link between fire suppression and heart attacks.

The investigators wish to determine the effect of exposure to wood smoke at concentrations found at the perimeter of a woodland fire on blood vessel function and clotting in healthy non-smoking male professional firefighters or volunteers. Volunteers will be studied before and after inhalation of wood smoke or clean air for one hour in a purpose built whole-body exposure chamber. The investigators will perform comprehensive vascular assessments thereafter.

Understanding the effects of wood smoke on the blood vessels and clotting will be an important first step in helping to protect firefighters from heart disease. Through research, the investigators hope to identify methods to minimise the risk of heart attacks in firefighters and understand the health effects of a major source of air pollution that is relevant to the general population.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–35 year

Sex eligibility

Male

Study type

Interventional

Phase

Not applicable

Primary location

Umeå University

Umeå, Västerbotten County, SE-901 85, Sweden

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Non-smoking healthy male firefighters or volunteers

Exclusion criteria

  • Current smoker or regular users of snus
  • History of lung or ischaemic heart disease
  • Malignant arrhythmia
  • Systolic blood pressure >190mmHg or <100mmHg
  • Renal or hepatic dysfunction
  • Previous history of blood dyscrasia
  • Unable to tolerate the supine position
  • Blood donation within the last 3 months
  • Recent respiratory tract infection within the past 4 weeks
  • Routine medication including aspirin and NSAIDs

Treatment and study plan

Forearm Vascular Study

Procedure

Forearm venous occlusion plethysmography to measure forearm blood flow during intra-arterial infusion of the vasodilators Verapamil (10-100 µg/min), bradykinin (100-1000 pmol/min), sodium nitroprusside (2-8 µg/min) and Acetylcholine (5-20 µg/min).

Other names: Other Names:, BK, SNP, ACh

Badimon Chamber

Procedure

Ex-vivo assessment of thrombus formation using the Badimon Chamber

Primary outcomes

  1. Forearm blood flow measured by venous occlusion plethysmography in response to infused vasodilators

    Time frame: 4-6 hours after exposure

Secondary outcomes

  1. Ex-vivo thrombus formation using the Badimon chamber

    Time frame: 2 hours after exposure

  2. Plasma t-PA and PAI concentrations following infusion of bradykinin

    Time frame: During forearm study, 4-6hours after exposure

Sponsors and collaborators

Lead sponsor

University of Edinburgh

Other

Collaborators

  • NHS Lothian
  • Umeå University

Registry information

Official study title

Effect of Woodsmoke on Vascular Function in Healthy Firefighters

Acronym: FIREWOOD

Important dates

Study start
2011
Primary completion
2014
Study completion
2014
First posted
Dec 20, 2011
Registry last updated
Jun 21, 2021

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.